China Biologic Products (CBPO) Reports Q4 EPS of $0.76/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018
March 6, 2019 5:00 PM EST-- 4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms;Net Income Up $59.4 Million YoY to $34.8 Million;Non-GAAP Adjusted Net Income Up 23.9% YoY in RMB terms --
-- FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms;Net Income Up 88.7% YoY to $128.1 Million; Non-GAAP Adjusted Net Income Up 0.6% YoY in RMB terms --
-- Issues Forecast for FY19 --
-- Board of Directors Extends previously Approved Share Repurchase Program --
BEIJING,... More
